PFS
TPTX

Prospera Financial Services’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Prospera Financial Services’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,014
Closed -$89K – 1684
2020
Q3 		$89K Buy
+1,014
New +$70.6K 0.03% 440

Other funds holding TPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Prospera Financial Services's TPTX Position: Q4 2020 in Review

Prospera Financial Services sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2020, closing a stake of 1,014 shares — an estimated $89K sold.

Prospera Financial Services first reported a position in TPTX in Q3 2020 and held it in 1 quarter. The position peaked at $89K in Q3 2020. 193 funds tracked by Wall St. Rank hold TPTX as of Q4 2020.

  • Prospera Financial Services reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Prospera Financial Services sold 1,014 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $89K.
  • Prospera Financial Services first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Prospera Financial Services's Turning Point Therapeutics, Inc. Common Stock position peaked at $89K in Q3 2020.
  • 193 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Prospera Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.